Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In Vivo.

Autor: Yuqi Jiang, Jie Xu, Kairui Yue, Chao Huang, Mengting Qin, Dongyu Chi, Qixin Yu, Yue Zhu, Xiaohan Hou, Tongqiang Xu, Min Li, Chou, C. James, Xiaoyang Li
Zdroj: Journal of Medicinal Chemistry; 1/13/2022, Vol. 65 Issue 1, p285-302, 18p
Databáze: Supplemental Index